A phase 3 randomized trial of voxelotor in sickle cell disease
When retatrutide is injected subcutaneously, it must cross the blood-brain barrier to reach central GLP-1 receptors
[1] Patients should also be aware that GLP-1 receptor agonists like Ozempic have been associated with an increased risk of gallbladder events, including cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation), which may present as right upper abdominal pain, particularly after fatty meals
A chemical reaction causes body odorit happens to every human being on the planet
These were observable as the spontaneous release of NO [67,68], as a counteraction of the adverse effect of a NOS blockade (i.e., L-NAME hypertension and pro-thrombotic effect), a counteraction of the adverse effect of NOS overstimulation (i.e., L-arginine hypotension and anti-thrombotic effect) [67,69], as control of vasomotor tone and as the activation of the Src-Caveolin-1-eNOS pathway [60,61]
And you're like, okay, where do I even start
